The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
Increases speed to market for drug developers working on nucleic acid therapeutics
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
CSPC will receive an upfront payment of $100 million from AstraZeneca
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
The inspection was concluded with zero observations
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Subscribe To Our Newsletter & Stay Updated
